Concepedia

A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors

Hanna K. Sanoff, Janine M. Davies, Christine M. Walko, William Irvin, Larry W. Buie, Kimberly Keller, Anastasia Ivanova, W. Chiu, Bert H. O’Neil, Thomas E. Stinchcombe,

Investigational New Drugs · 2010 · 14 citations · 19 references

DOIFull text

Open access

Concepts

References

19

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

David Cunningham, Yves Humblet, Salvatore Siena et al. · New England Journal of Medicine · 2004 · 5K citations · Full text

, , +17

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

Joaquim Bellmunt, Christine Théodore, T. Demkov et al. · Journal of Clinical Oncology · 2009 · 779 citations · Full text

, , +10

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Harold J. Burstein, Lyndsay N. Harris, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2003 · 345 citations

, , +17

The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.

Jo Ann Hirth, Paul B. Watkins, Myla Strawderman et al. · PubMed · 2000 · 202 citations

, , +17